Author

Fei Peng

Clemson University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Assay:imaging· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

Allison Reno· 1 shared Brandi Baldus· 1 shared Chunyan SuniD· 1 shared Deyao ShiiD· 1 shared Elizabeth McLaughlin· 1 shared Fengjuan FaniD· 1 shared Hai XiaoiD· 1 shared Jianan TangiD· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Allison Reno

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Evaluation of a Deep Learning Based Approach to Computational Label Free Cell Viability Quantification

Allison Reno, Jianan Tang, Madeline Sudbeck, Precious Fe Custodio, Brandi Baldus, Elizabeth McLaughlin, Fei Peng, Hai Xiao

This paper evaluates a deep learning approach to estimate cell viability without stains by classifying live/dead cells and counting total cells using ResNet CNNs.

bioRxiv · Aug 29, 2024 · PreprintCell Biology

An IPI based immune prognostic model for diffuse large B-cell lymphoma

Shidai Mu, Deyao Shi, Lisha Ai, Fengjuan Fan, Fei Peng, Chunyan Sun, Yu Hu

The paper constructs an IPI-based immune prognostic model for DLBCL using gene expression data, showing high-risk patients have shorter survival and higher potential response to ICB therapy.

bioRxiv · Mar 3, 2021 · PreprintGenomics